Zerigo is the only consumer delivered solution available to counteract the massive growth in high-priced dermatological biologics ($100K – $200K for each patient, for each year, forever) in the treatment of psoriasis, vitiligo, and eczema. Zerigo combines smart technology with personal support to treat chronic skin conditions with its patented NB-UVB device to deliver care when and where it’s convenient for the patient. The treatment is controlled and data-captured by the Zerigo platform and overseen by the company’s Care Partners to ensure every patient experiences the most effective outcome, and at a fraction of the never-ending cost of dermatological biologics.

Read More About Zerigo

Go to Top